Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig I Coleman

Showing results (11-20 of 351) with videos related to

Pageof 36
Sort By:
Connecticut Medicine|February 10, 2007
A comparison of different protease inhibitors on coronary heart disease riskCraig I Coleman, C Michael White
The American Journal of Cardiology|June 10, 2026
Burden of wild-type transthyretin amyloid cardiomyopathy hospitalizationsAnthony Del Debbio, Craig I Coleman
Plos One|June 22, 2016
Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United StatesCraig I Coleman, Muralikrishna Tangirala, Thomas Evers
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 9, 2026
Reporting of atrial fibrillation with bispecific T-cell engagers in the Food and Drug Administration Adverse Event Reporting SystemBrian Portela, Osama Abdelghany, Craig I Coleman
Journal of Fungi (Basel, Switzerland)|April 27, 2026
Duration of Antifungal Therapy in Disseminated Coccidioidomycosis Patients: A Real-World Treatment Utilization StudyCraig I Coleman, Belinda Lovelace, Mark Bresnik
International Journal of Cardiology|April 4, 2016
Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United StatesCraig I Coleman, Muralikrishna Tangirala, Thomas Evers
Research and Practice in Thrombosis and Haemostasis|March 10, 2025
Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortalityHuiqiao Fan, Youssef Bessada, Craig I Coleman
Heart, Lung & Circulation|May 23, 2017
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German PracticeCraig I Coleman, W Frank Peacock, Matthias Antz
Connecticut Medicine|October 9, 2002
Budesonide: its role in Crohn's disease therapyCraig I Coleman, Prabashni Reddy, C Michael White
Pharmacotherapy|November 16, 2002
The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasiaCraig I Coleman, John H Hebert, Prabashni Reddy
Pageof 36

Showing results (11-20 of 351) with videos related to

Sort By:
Pageof 36
Connecticut Medicine|February 10, 2007
A comparison of different protease inhibitors on coronary heart disease riskCraig I Coleman, C Michael White
The American Journal of Cardiology|June 10, 2026
Burden of wild-type transthyretin amyloid cardiomyopathy hospitalizationsAnthony Del Debbio, Craig I Coleman
Plos One|June 22, 2016
Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United StatesCraig I Coleman, Muralikrishna Tangirala, Thomas Evers
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 9, 2026
Reporting of atrial fibrillation with bispecific T-cell engagers in the Food and Drug Administration Adverse Event Reporting SystemBrian Portela, Osama Abdelghany, Craig I Coleman
Journal of Fungi (Basel, Switzerland)|April 27, 2026
Duration of Antifungal Therapy in Disseminated Coccidioidomycosis Patients: A Real-World Treatment Utilization StudyCraig I Coleman, Belinda Lovelace, Mark Bresnik
International Journal of Cardiology|April 4, 2016
Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United StatesCraig I Coleman, Muralikrishna Tangirala, Thomas Evers
Research and Practice in Thrombosis and Haemostasis|March 10, 2025
Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortalityHuiqiao Fan, Youssef Bessada, Craig I Coleman
Heart, Lung & Circulation|May 23, 2017
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German PracticeCraig I Coleman, W Frank Peacock, Matthias Antz
Connecticut Medicine|October 9, 2002
Budesonide: its role in Crohn's disease therapyCraig I Coleman, Prabashni Reddy, C Michael White
Pharmacotherapy|November 16, 2002
The effect of phytosterols on quality of life in the treatment of benign prostatic hyperplasiaCraig I Coleman, John H Hebert, Prabashni Reddy
Pageof 36